Critical Diagnostics

ST2 levels in blood predict patient prognosis

Clinical Advisor	Institutional Affiliations
James Januzzi, MD, FACC	Director, Cardiac Intensive Care Unit, Massachusetts General Hospital Associate Professor of Medicine, Harvard Medical School
Alan Maisel, MD, FACC	Professor of Medicine, University of California, San Diego Director, Coronary Care Unit, Heart Failure Program, VA Medical Center La Jolla
David Morrow, MD, MPH, FACC, FAHA	Associate Professor, Harvard Medical School Clinical Investigator, TIMI Study Group Associate Physician, Brigham & Women’s Hospital
Frank Peacock, MD, FACEP	Vice Chair of Emergency Medicine, Cleveland Clinic Associate Professor, Ohio State University Board of Directors, Society of Chest Pain
Alan Wu, PhD, DABCC	Chief of Clinical Chemistry and Toxicology, San Francisco General Hospital Professor, Laboratory Medicine, University of California, San Francisco
Donna Edmonds	CEO, Virginia Biosciences Commercialization Center Former COO & SVP, Vital Sensors Inc, Ischemia Technologies, Spectral Diagnostics Former SVP, Baxter Diagnostics Division